Observational study in asthmatics patients after reduction/withdrawal of Omalizumab for good asthma control: real life experience from a Severe Asthma Unit

Observational study in asthmatics patients after reduction/withdrawal of Omalizumab for good asthma control: real life experience from a Severe Asthma Unit

Methods Patients with severe asthma treated with OMA >= 5 years, who had good or excellent global evaluation of treatment effectiveness (GETE), Asthma Control Test (ACT) >= 20, no severe exacerbations in the previous year, and stable lung function, underwent a progressive OMA dose reduction pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB11-AB11
Hauptverfasser: Bastidas Parlanti, Jose Alessandro, Márquez, Dorkas M, Bobolea, Irina, MD, Herrera, Lys Herraez, Moguel, Ismael García, Fernández, Consuelo Rodríguez
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Asthma
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Methods Patients with severe asthma treated with OMA >= 5 years, who had good or excellent global evaluation of treatment effectiveness (GETE), Asthma Control Test (ACT) >= 20, no severe exacerbations in the previous year, and stable lung function, underwent a progressive OMA dose reduction protocol.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.089